Treatment of persistent post-traumatic headache with OnabotulinumtoxinA: Response rates according to clinical phenotype

Authors
Category Primary study
ConferenceHeadache
Year 2021
This article has no abstract
Epistemonikos ID: cd8bb152b8fdc77524c8d580633480a0e0befe14
First added on: Apr 30, 2026